Ingrid De Meester

17PUBLICATIONS
62CO-AUTHORS
Toxicology (incl. clinical toxicology)Molecular targetsPredictive and prognostic markersHaematological tumoursBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 29, 2025
Selective and Orally Bioavailable Dipeptidyl Peptidase 9 Inhibitors with Potent Pyroptosis Induction Properties.

Nicolò Filippi, Kathleen Mertens, Joni De Loose

|Oct 14, 2025
Structure-Property Investigation of New "KetoFAPI" Inhibitors of Fibroblast Activation Protein (FAP): Discovery of Highly Potent, Selective Compounds with Prolonged Residence Times and Promising Radiotheranostic Potential.

Pawel Brzeminski, Emile Verhulst, Adrian Fabisiak

|Aug 12, 2025
Synthesis and Preclinical Evaluation of Druglike 18F-Labeled Fibroblast Activation Protein (FAP) Inhibitors with Enhanced Tumor Retention.

Karuna Adhikari, Sergei Grintsevich, Anke de Groot

|Jul 10, 2025
Fibroblast activation protein on human natural killer cells: insights from natural killer cell activation and crosstalk with cancer-associated fibroblasts.

Yentl Van Rymenant, Anke de Groot, Laura Dirkx

|Sep 27, 2024
Cosolvent Molecular Dynamics Applied to DPP4, DPP8 and DPP9: Reproduction of Important Binding Features and Use in Inhibitor Design.

Olivier Beyens, Sam Corthaut, Sarah Peeters

|Apr 24, 2024
Druglike, 18F-labeled PET Tracers Targeting Fibroblast Activation Protein.

Muhammet Tanc, Nicolò Filippi, Yentl Van Rymenant

Pageof 3

Frequent Collaborators

6 joint publications

Pieter Van der Veken

4 joint publications

Emilie De Hert

4 joint publications

Anne-Marie Lambeir

4 joint publications

Koen Augustyns